about
Genetic and epigenetic events in diabetic wound healing.NET silencing by let-7i in postural tachycardia syndrome.Vascular histone deacetylation by pharmacological HDAC inhibition.Investigation into the biological properties of the olive polyphenol, hydroxytyrosol: mechanistic insights by genome-wide mRNA-Seq analysis.Clonogenic assay: adherent cellsInvestigation of the biological properties of Cinnulin PF in the context of diabetes: mechanistic insights by genome-wide mRNA-Seq analysis.HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes.Epigenetic mechanisms in the pathogenesis of diabetic foot ulcers.Multi-Cellular Transcriptional Analysis of Mammalian Heart Regeneration.Improving understanding of chromatin regulatory proteins and potential implications for drug discovery.Metabolism and chromatin dynamics in health and disease.A pipeline for the identification and characterization of chromatin modifications derived from ChIP-Seq datasets.RNA sequencing supports distinct reactive oxygen species-mediated pathways of apoptosis by high and low size mass fractions of Bay leaf (Lauris nobilis) in HT-29 cells.Systems approach to the pharmacological actions of HDAC inhibitors reveals EP300 activities and convergent mechanisms of regulation in diabetes.MeCP2 interacts with chromosomal microRNAs in brain.Pharmacological Histone Deacetylation Distinguishes Transcriptional Regulators.HDAC Inhibition in Vascular Endothelial Cells Regulates the Expression of ncRNAs.Current perspectives in Set7 mediated stem cell differentiation.The Accessible Chromatin Landscape of Murine and Human Cardiomyocyte DevelopmentGalectin-3 deficiency ameliorates fibrosis and remodelling in dilated cardiomyopathy mice with enhanced Mst1 signalingFamilial early onset Parkinson's disease caused by a homozygous frameshift variant in PARK7: Clinical features and literature update
P50
Q30397422-60B49CAA-24BA-4024-8EA9-19F2CCE464B2Q33168474-20765EFE-534A-490C-AC39-4100422489EDQ33994818-C71590A6-A21C-4FF5-9244-24A45FF2DB81Q34033276-98A70323-0930-4619-BF3B-8D5313310649Q35394906-A1A990B6-73C9-42BF-96A4-3D57B0BFFEC8Q36159811-0F3105AB-FF2F-4D23-87B4-D3D1848F9F27Q36212830-7CED2DBA-E353-4855-B25F-65502759DE0EQ38022175-7BCD4009-E57D-4260-82F2-A78E5A17D467Q38667300-78832591-558F-4BE3-9103-8A64FF38CFE4Q38753861-9F416A31-126B-49F4-8BF1-29DFCC3250D9Q38971129-71C366FF-A6FE-4371-9E48-F73400677B73Q44219243-2A0E3270-2F24-42CC-B722-96895FFD0CE9Q46709248-B5C463FA-9145-43CC-9669-011077DCDEC2Q48666421-7790969F-7186-477D-BDF1-2F3B1B084076Q50140785-3D953514-2DF6-4693-B033-A40AE9023860Q51339291-8B8059FC-C215-4D12-BAD9-2959C83928A2Q55323751-41DFEF67-E37A-4DCD-B20F-A36DB924171EQ55456138-A7305837-52BD-431E-8A0F-AFF6825EEF75Q58049814-74FAEB4E-9572-4E3F-9603-811ACDE261F3Q58615231-8969EE74-82D0-4208-AA5D-D8EDF81D7E34Q64770103-62B25526-7C03-4A0D-8F55-565110008A2C
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0002-8954-4930
@en
name
Haloom Rafehi
@ast
Haloom Rafehi
@en
Haloom Rafehi
@es
Haloom Rafehi
@nl
type
label
Haloom Rafehi
@ast
Haloom Rafehi
@en
Haloom Rafehi
@es
Haloom Rafehi
@nl
prefLabel
Haloom Rafehi
@ast
Haloom Rafehi
@en
Haloom Rafehi
@es
Haloom Rafehi
@nl
P108
P106
P108
P31
P496
0000-0002-8954-4930